HPV16 E2 could act as down-regulator in cellular genes implicated in apoptosis, proliferation and cell differentiation

Virology Journal

Volumn 8, Issue , 2011, Pages

  Ramírez Salazar, Eric ^a   Centeno, Federico ^a,c   Nieto, Karen ^a,d   Valencia Hernández, Armando ^a,e   Salcedo, Mauricio ^b   Garrido, Efraín ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b HOSPITAL DE ONCOLOGÍA   (Mexico)

^c HOSPITAL GENERAL DE MÉXICO   (Mexico)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e Mexican Institute of the Industrial Property   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CELL PROTEIN; CHEMOKINE; CYTOKINE; JAGGED1; MITOGEN ACTIVATED PROTEIN KINASE 13; MYC PROTEIN; PLATELET DERIVED GROWTH FACTOR; VIRUS PROTEIN; DNA BINDING PROTEIN; E2 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; INFLAMMATION; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ADENOVIRUS; CELL LINE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HOST PATHOGEN INTERACTION; METABOLISM; PATHOGENICITY;

HUMAN PAPILLOMAVIRUS;

ADENOVIRIDAE; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC VECTORS; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MICROARRAY ANALYSIS; ONCOGENE PROTEINS, VIRAL;

EID: 79956191057     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-247     Document Type: Article

References (58)

1. HPV: from infection to cancer. MA Stanley MR Pett N Coleman, Biochem Soc Trans 2007 35 1456 1460 10.1042/BST0351456 18031245
2. The regulation of cell proliferation by the papillomavirus early proteins. NA Hamid C Brown K Gaston, Cell Mol Life Sci 2009 66 1700 1717 10.1007/s00018-009-8631-7 19183849
3. Papillomavirus DNA replication - from initiation to genomic instability. M Kadaja T Silla E Ustav M Ustav, Virology 2009 384 360 368 10.1016/j.virol. 2008.11.032 19141359
4. Variations in the association of papillomavirus E2 proteins with mitotic chromosomes. JG Oliveira LA Colf (Pubitemid 43212219)
5. Disruption of the E2 gene is a common and early event in the natural history of cervical human papillomavirus infection: a longitudinal cohort study. SI Collins C Constandinou-Williams K Wen LS Young S Roberts PG Murray CB Woodman, Cancer Res 2009 69 3828 3832 10.1158/0008-5472.CAN-08-3099 19401452
6. Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions. M Cricca S Venturoli E Leo S Costa M Musiani M Zerbini, J Virol Methods 2009 158 180 183 10.1016/j.jviromet.2009.01.005 19187786
7. Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? M Pett N Coleman, J Pathol 2007 212 356 367 10.1002/path.2192 17573670 (Pubitemid 47099012)
8. The human papillomavirus type 8 E2 protein suppresses beta4-integrin expression in primary human keratinocytes. M Oldak H Smola M Aumailley F Rivero H Pfister S Smola-Hess, J Virol 2004 78 10738 10746 10.1128/JVI.78.19.10738- 10746.2004 15367640 (Pubitemid 39258399)
9. Human papillomavirus E2 down-regulates the human telomerase reverse transcriptase promoter. D Lee HZ Kim KW Jeong YS Shim I Horikawa JC Barrett J Choe, J Biol Chem 2002 277 27748 27756 10.1074/jbc.M203706200 12019268 (Pubitemid 34966719)
10. The hinge region of the human papillomavirus type 8 E2 protein activates the human p21(WAF1/CIP1) promoter via interaction with Sp1. G Steger C Schnabel HM Schmidt, J Gen Virol 2002 83 503 510 11842244 (Pubitemid 34182994)
11. The Papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiation. D Hadaschik K Hinterkeuser M Oldak HJ Pfister S Smola-Hess, J Virol 2003 77 5253 5265 10.1128/JVI.77.9.5253-5265.2003 12692227 (Pubitemid 36460939)
12. Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF. S Mole SG Milligan SV Graham, J Virol 2009 83 357 367 10.1128/JVI.01414-08 18945764
13. Transcription-independent triggering of the extrinsic pathway of apoptosis by human papillomavirus 18 E2 protein. C Demeret A Garcia-Carranca F Thierry, Oncogene 2003 22 168 175 10.1038/sj.onc.1206108 12527886 (Pubitemid 36174174)
14. Disruption of the human papillomavirus type 16 E2 gene protects cervical carcinoma cells from E2F-induced apoptosis. AM Sanchez-Perez S Soriano AR Clarke K Gaston, J Gen Virol 1997 78 Pt 11 3009 3018 9367388 (Pubitemid 27480841)
15. The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway. K Webster J Parish M Pandya PL Stern AR Clarke K Gaston, J Biol Chem 2000 275 87 94 10.1074/jbc.275.1.87 10617590 (Pubitemid 30038957)
16. Interaction between the HPV-16 E2 transcriptional activator and p53. P Massimi D Pim C Bertoli V Bouvard L Banks, Oncogene 1999 18 7748 7754 10618715 (Pubitemid 30052759)
17. E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death. JL Parish A Kowalczyk HT Chen GE Roeder R Sessions M Buckle K Gaston, J Virol 2006 80 4580 4590 10.1128/JVI.80.9.4580-4590.2006 16611918
18. Specific in vitro interaction between papillomavirus E2 proteins and TBP-associated factors. E Carrillo E Garrido P Gariglio, Intervirology 2004 47 342 349 10.1159/000080878 15564746 (Pubitemid 39541281)
19. Accelerated titering of adenoviruses. B Bewig WE Schmidt, Biotechniques 2000 28 870 873 10818691 (Pubitemid 30263001)
20. Selective extraction of polyoma DNA from infected mouse cell cultures. B Hirt, J Mol Biol 1967 26 365 369 10.1016/0022-2836(67)90307-5 4291934
21. Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. PD Thomas A Kejariwal N Guo H Mi MJ Campbell A Muruganujan B Lazareva-Ulitsky, Nucl Acids Res 2006 34 645 650 10.1093/nar/gkl229 16912992
22. A methodology for global validation of microarray experiments. M Miron OZ Woody A Marcil C Murie R Sladek R Nadon, BMC Bioinformatics 2006 7 333 10.1186/1471-2105-7-333 16822306
23. The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications. V Melotte X Qu M Ongenaert W van Criekinge AP de Bruine HS Baldwin M van Engeland, FASEB J
24. A regulatory role for p38 delta MAPK in keratinocyte differentiation. Evidence for p38 delta-ERK1/2 complex formation. T Efimova AM Broome RL Eckert, J Biol Chem 2003 278 34277 34285 10.1074/jbc.M302759200 12810719 (Pubitemid 37553271)
25. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer. B Cohen M Shimizu J Izrailit NF Ng Y Buchman JG Pan J Dering M Reedijk, Breast Cancer Res Treat 123 113 124
26. Inhibition of HPV-16 E7 oncogenic activity by HPV-16 E2. N Gammoh E Isaacson V Tomaic DJ Jackson J Doorbar L Banks, Oncogene 2009 28 2299 2304 10.1038/onc.2009.78 19421149
27. Modulation of apoptosis by early human papillomavirus proteins in cervical cancer. A Lagunas-Martinez V Madrid-Marina P Gariglio, Biochim Biophys Acta 2009
28. Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma. F Thierry, Virology 2009 384 375 379 10.1016/j.virol.2008.11.014 19064276
29. E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors. F Stubenrauch IM Leigh H Pfister, J Virol 1996 70 119 126 8523515 (Pubitemid 126508776)
30. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. SH Tan B Gloss HU Bernard, Nucleic Acids Res 1992 20 251 256 10.1093/nar/20.2.251 1311070
31. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. SH Tan LE Leong PA Walker HU Bernard, J Virol 1994 68 6411 6420 8083979 (Pubitemid 24294891)
32. E2 and the co-activator p300 can cooperate in activation of the human papillomavirus type 16 early promoter. U Kruppel A Muller-Schiffmann SE Baldus S Smola-Hess G Steger, Virology 2008 377 151 159 10.1016/j.virol.2008.04.006 18495195
33. Tax1BP1 interacts with papillomavirus E2 and regulates E2-dependent transcription and stability. X Wang SR Naidu F Sverdrup EJ Androphy, J Virol 2009 83 2274 2284 10.1128/JVI.01791-08 19109394
34. Transcriptional control and cell type specificity of HPV gene expression. HU Bernard D Apt, Arch Dermatol 1994 130 210 215 10.1001/archderm.130.2.210 8304760 (Pubitemid 24056048)
35. The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription. T Chong D Apt B Gloss M Isa HU Bernard, J Virol 1991 65 5933 5943 1656080
36. Transcriptional regulation of human papillomavirus type 16 LCR by different C/EBPbeta isoforms. L Struyk E van der Meijden R Minnaar V Fontaine I Meijer J ter Schegget, Mol Carcinog 2000 28 42 50 10.1002/(SICI)1098- 2744(200005)28:1<42::AID-MC6>3.0.CO;2-8 10820487 (Pubitemid 30252926)
37. trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors. M Ushikai MJ Lace Y Yamakawa M Kono J Anson T Ishiji S Parkkinen N Wicker ME Valentine I Davidson,, et al. J Virol 1994 68 6655 6666 8083999
38. Functional interaction between p/CAF and human papillomavirus E2 protein. D Lee SG Hwang J Kim J Choe, J Biol Chem 2002 277 6483 6489 10.1074/jbc.M105085200 11744716 (Pubitemid 34968445)
39. Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300. A Muller A Ritzkowsky G Steger, J Virol 2002 76 11042 11053 10.1128/JVI.76.21.11042-11053.2002 12368347 (Pubitemid 35176221)
40. TAF1 interacts with and modulates human papillomavirus 16 E2-dependent transcriptional regulation. F Centeno E Ramirez-Salazar E Garcia-Villa P Gariglio E Garrido, Intervirology 2008 51 137 143 10.1159/000141706 18580066
41. Interaction of human papillomavirus 8 regulatory proteins E2, E6 and E7 with components of the TFIID complex. C Enzenauer G Mengus A Lavigne I Davidson H Pfister M May, Intervirology 1998 41 80 90 10.1159/000024918 9820841 (Pubitemid 28537633)
42. Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure. J Ham G Steger M Yaniv, EMBO J 1994 13 147 157 8306958
43. Alleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA polymerase II-TFIIF preinitiation complex. SY Hou SY Wu T Zhou MC Thomas CM Chiang, Mol Cell Biol 2000 20 113 125 10.1128/MCB.20.1.113-125.2000 10594014 (Pubitemid 30002553)
44. Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB. NM Rank PF Lambert, J Virol 1995 69 6323 6334 7666533
45. The bovine papillomavirus 1 E2 protein contains two activation domains: one that interacts with TBP and another that functions after TBP binding. G Steger J Ham O Lefebvre M Yaniv, EMBO J 1995 14 329 340 7835344
46. Genome wide expression analysis in HPV16 cervical cancer: identification of altered metabolic pathways. C Perez-Plasencia G Vazquez-Ortiz R Lopez-Romero P Pina-Sanchez J Moreno M Salcedo, Infect Agent Cancer 2007 2 16 10.1186/1750-9378-2-16 17822553
47. Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells. T Rampias E Boutati E Pectasides C Sasaki P Kountourakis P Weinberger A Psyrri, Mol Cancer Res 8 433 443
48. Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways. SJ Smeets M van der Plas TB Schaaij-Visser EA van Veen J van Meerloo BJ Braakhuis RD Steenbergen RH Brakenhoff, Int J Cancer
49. Down-regulation of E-cadherin is closely associated with progression of cervical intraepithelial neoplasia (CIN), but not with high-risk human papillomavirus (HPV) or disease outcome in cervical cancer. M Branca C Giorgi M Ciotti D Santini L Di Bonito S Costa A Benedetto D Bonifacio P Di Bonito P Paba,, et al. Eur J Gynaecol Oncol 2006 27 215 223 16800245 (Pubitemid 43953413)
50. Rho GTPase function in tumorigenesis. R Karlsson ED Pedersen Z Wang C Brakebusch, Biochim Biophys Acta 2009 1796 91 98 19327386
51. Constitutively active RhoA inhibits proliferation by retarding G(1) to S phase cell cycle progression and impairing cytokinesis. P Morin C Flors MF Olson, Eur J Cell Biol 2009 88 495 507 10.1016/j.ejcb.2009.04.005 19515453
52. Cyclin-dependent kinases and S phase control in mammalian cells. RA Woo RY Poon, Cell Cycle 2003 2 316 324 12851482
53. Apoptosis and autophagy: Regulation of caspase-9 by phosphorylation. LA Allan PR Clarke, FEBS J 2009 276 6063 6073 10.1111/j.1742-4658.2009.07330.x 19788417
54. Methylation at CpG islands in intron 1 of EGR2 confers anhancer-like activity. M Unoki Y Nakamura, FEBS Letters 2003 554 67 72 10.1016/S0014-5793(03) 01092-5 14596916 (Pubitemid 37324816)
55. EGR2 induces apoptosis in various cancer lines by direct transactivation of BNIP3 and BAK. M Unoki Y Nakamura, Oncogene 2003 22 2172 2185 10.1038/sj.onc.1206222 12687019 (Pubitemid 36539567)
56. HPV8 early genes modulate differentiation and cell cycle of primary human adult keratinocytes. B Akgul L Ghali D Davies H Pfister IM Leigh A Storey, Exp Dermatol 2007 16 590 599 10.1111/j.1600-0625.2007.00569.x 17576239 (Pubitemid 46958565)
57. Structure and functions of keratin proteins in simple, stratified, keratinized and cornified epithelia. HH Bragulla DG Homberger, J Anat 2009 214 516 559 10.1111/j.1469-7580.2009.01066.x 19422428
58. Making an epidermis. MI Koster, Ann N Y Acad Sci 2009 1170 7 10 10.1111/j.1749-6632.2009.04363.x 19686098